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ABSTRACT
Pediatric oncology patients are at an increased risk for malnutrition related to their
diagnosis and corresponding treatment. It is essential that accurate and reliable methods
of measuring energy needs are used throughout treatment to avoid increased risk of
morbidity and mortality. The primary objective of the study is to determine if the energy
expenditure obtained by a standard energy equation and by the MedGem® accurately
predicts needs in pediatric oncology patients as compared to the gold standard indirect
calorimeter. The three measurements were tested on the same day for patients aged 7-17
years. The data was analyzed using a one way analysis of variance, and Bonferroni to
determine significance. With p-value of 0.0018, there is a statistically significant
difference between the three methods used. Further testing is required to support the
reliability of the MedGem® in pediatric oncology.
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CHAPTER 1
INTRODUCTION
Background
Malnutrition as defined by the Academy of Nutrition and Dietetics (AND) is a
condition of “Inadequate intake of protein and/or energy over prolonged periods of time
resulting in loss of fat stores and/or muscle stores including starvation-related
malnutrition, chronic disease or condition-related malnutrition, and acute disease or
injury-related malnutrition”.1
Numerous and severe complications have been associated with the various levels
of malnutrition, particularly in the pediatric oncology population.2–5 These complications
include increased mortality rates in both underweight and overweight patients, deficits in
weight-for-height measures, extending the length of hospital stay, and long-term
survivor late effects, such as, osteopenia and obesity.6
In light of the heightened potential for negative physical and psychological
consequences associated with malnutrition, early detection is paramount in the pediatric
oncology population. Specifically, early and accurate identification of energy
requirements is needed as this may prevent the development of nutrient deficits, lessen
the need for prolonged aggressive nutritional support, improve tolerance to chemotherapy
and other treatments, improve overall quality of life, and decrease mortality rates.2–8
Literary Review
Malnutrition
Malnutrition is an undesirable consequence produced by an imbalance of
nutrients, or more specifically states of underfeeding or over-feeding.9 In the literature,
1

malnutrition is assessed by anthropometric marker including body mass index (BMI),
weight-for-height (WFH), skin folds, or mid-upper arm circumference (MAC).9–11
Malnutrition is further categorized by degree of the nutrition deficit using cut-off values
expressed in percentiles, z-scores, ratios, and percentages.10 In some cases, achieving
nutrition parameters categorized for healthy weight status are not met due to
miscalculation of energy requirements. In these cases, inaccurate calculation will directly
result in an imbalance of nutrients for growing children, which will increase the overall
risk for malnutrition or prevent catch up growth in those malnourished. Therefore,
accurate assessment and monitoring of energy expenditure requirements is vital.
Especially in the pediatric oncology population due to their increased energy
requirements for growth, in addition to, their varying metabolic states associated with the
cancer diagnosis and accompanying treatment regimen6.
Prevalence of Malnutrition
The prevalence of malnutrition in pediatric oncology varies and is dependent on
diagnosis. Pediatric patients who present with leukemia have the lowest prevalence of
malnutrition with 5-10% at diagnosis and 0-5% during treatment.10,12 The highest
prevalence of malnutrition in pediatric oncology is seen in children with neuroblastoma.
The neuroblastoma population has seen up to 50% of malnutrition at diagnosis, and
maintains relatively high prevalence at 20-50% throughout treatment.10,13 However,
there is a lack of substantial data on malnutrition within the pediatric solid tumor
population, although some studies have estimated that there is a 0-30% prevalence of
malnutrition in solid tumor patients.10
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Risk Factors for Malnutrition
Due to a relatively high prevalence in pediatric oncology patients, risks of
malnutrition and the subsequent altered metabolic states must be assessed to avoid further
complications in the disease state. Patients with low or higher than normal BMIs at the
time of diagnosis typically have an increased risk for malnutrition during treatment. The
likelihood of malnutrition is also increased when the cancerous tumor has spread from
the primary site, or the individual has tumors located in the head and/or neck region.
Combined treatment modalities (surgery, radiotherapy, and antineoplastic schedules)
produce injuries to major organ systems such as pancreas and liver.14 As a result of the
oncology treatment, patients experience a series of nutrient depleting complications, such
as diarrhea and vomiting. These complications will contribute to fluid/electrolyte loss
and macro- and micronutrient deficiencies and ultimately alter the metabolic state.5,6,14 A
sustained hyper-metabolic state, over an extended time period, can make a large
contribution to negative energy balance and wasting, if not compensated for by increase
in energy intake.15
Consequences of Malnutrition
Patients may experience detrimental short and long-term consequences or even
death if accurate assessment of risk factors and timely interventions are not implemented.
Inaba, et. al confirmed that overweight/obese (85th-95th percentile) children with acute
myeloid lymphoma have significantly worse survival rates. Loeffen, et. al analyzed 269
childhood oncology patients, and also determined survival was significantly worse
(p=0.01) for patients who were malnourished at diagnosis (n=14) when compared to
those that were determined to be well-nourished or over-nourished (n=248). In addition
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to having lower survival, individuals classified as malnourished also experience
complications associated with dosing of chemotherapy. Important factors, such as, total
body surface area that is used to accurately dose patients are affected by malnutrition,
which alters total body surface area, and leads to improper dosing techniques. In addition,
malnutrition may cause a change in nutrient pathways that could alter the pharmokinetics
resulting in a decreased drug efficacy and possibly lower response to therapies.6
Numerous nutrition related complications have been identified in the pediatric
oncology survivorship population this phenomena may be associated weight status
changes that occur secondary to treatment. Warner, et. al noted that pediatric ALL
patients have lower energy expenditure during activity.16 Alterations in energy
expenditure during treatment may in part lead to the increased incidence of obesity in
survivorship. A rise in post-treatment obesity has been noted, increasing the risk for
metabolic syndrome and high risk cardiovascular diseases.14 Therefore, an understanding
of patients’ energy requirements are necessary to prevent adverse short and long term
outcomes, ensure maintenance of a healthy body weight, and avoid over- or
underfeeding.
Methods of Indirect Calorimetry
Practical validated tools for estimating patients’ energy requirements are pertinent
in a clinical setting.17 There are two methods of energy measurement known as direct
and indirect calorimetry. Direct calorimetry quantifies total energy expenditure (TEE)
via a thermally sealed chamber.18 Direct calorimetry is very accurate, but expensive,
requires tremendous technical expertise, and is not readily available.18 Therefore, the
most commonly used method of measurement is indirect calorimetry.18–20 Indirect
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calorimetry measures for energy expenditure and 24-hour caloric requirements reflected
by the resting energy expenditure (REE) and substrate utilization known as the
respiratory quotient (RQ).19 Energy measurement via indirect calorimetry can be
performed in two ways: Metabolic cart and MedGem®. Additionally, energy
expenditure equations can be used to determine energy needs.
Metabolic Cart
The gold standard method of measuring resting energy expenditure (REE) is
known as the metabolic cart (ICREE). The specific equipment for this study is known as
the Ultima Cardiopulmonary Gas Exchange System (Medical Graphics Corporation,
Minneapolis, Minnesota).The amount of oxygen (VO2) inspired and carbon dioxide
(VCO2) expired are measured, and the volume of gas exchanged is equated to kcals per
milliliters of oxygen consumed, also known as energy constants.19 The computer system
on the ICREE then converts the energy constants to REE. The entire process takes
approximately thirty minutes, with ten minutes is used for the patient to reach a steady
state of breathing.
The ICREE is not without issue. The high cost of maintenance, transportation of
patient from room to Pulmonary Lab, and requirement for operation expertise are
additional complications that make the metabolic cart impractical to use frequently in the
clinical setting.21
MedGem®
A portable, FDA approved hand-held indirect calorimeter device known as the
MedGem® (MGREE) distributed by MicroLife Medical Home Solutions, Inc. is a less
expensive method of assessing REE. Given the ease and portability of the MGREE,
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suggest that it may have potential for use in pediatric research and clinical care settings.22
The MGREE contains an oxygen analyzer that can measure the measurement of VO2, but
does not account for VCO2. Instead of accounting for VCO2, the MGREE assumes a
constant RQ of 0.85.21 The entire assessment takes ten minutes. The first two minutes
allow the patient to obtain a steady state of airflow.21 The system can self-terminate if a
steady state is not achieve through the duration of the anaylsis.21
One study evaluated the reliability and validity of the MGREE in 100 healthy
children, and found that the MGREE had an average of 103 kcal/day difference between
the metabolic cart, and was deemed to be within the limits of error for the study.22
Another study measured the accuracy of the MGREE in 20 healthy adults (18-35 years of
age).23 The purpose of the study was to evaluate the reliability of the MGREE during
different physiological conditions (Fed energy expenditure, resting energy expenditure,
and activity energy expenditure).23 The researchers determined that there was no
significant differences between the means of the ICREE and MGREE.23
Conversely, another study performed by Reeves et. al, compared the validity and
reliability of the MGREE to the metabolic cart in 15 adult oncology patients and 15
healthy subjects. The MGREE was reliable on the individual level for healthy patients,
but failed to accurately predict the REE in cancer patients (-11% difference).21 The
accuracy of the MGREE has yet to be compared to standard indirect calorimetry in the
pediatric oncology population, and may prove to be a valid tool.
Prediction Equations
The limited availability of both the ICREE and MGREE results in the frequent
utilization of predicative equations to estimate REE. There are more than 200 predictive
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equation utilized depending on their appropriateness for given population. Prediction
equations are generally derived from healthy subjects during resting metabolism with an
added stress factor or adjustments for variables of illness.24 However, the energy
requirements in hospitalized patients greatly vary due to metabolic rates ranging from
hypo-metabolic to hypermetabolic.2 The variability in the metabolic stages has proven to
be a challenge for individuals attempting to predict patient energy requirements.
One study estimated that feedings based on the use of prediction equations are routinely
500 to 2000 kcals per day more than that of a more precise indirect calorimeter.19 The
method of prediction equations is the least expensive and most practical application for
estimating energy requirements. However, due to its inaccuracy, the equations are not
optimal source in wavering metabolic states.
Conclusion
Malnutrition in the pediatric oncology patients has a multitude of adverse short
and long-term outcomes that can directly alter the fate of a young, oncology patient.
Having access to a valid, reliable tool to measure energy expenditure in the pediatric
oncology population is vital to prevent the onset of malnutrition. The two tools for
measuring resting energy expenditure and the one equation all have positive and negative
attributes that must be compared and analyzed to determine which tool is the most
beneficial to the sensitive population of pediatric oncology.
Rationale of This Study
The primary objective of this study is to determine if the energy expenditure
obtained by the World Health Organization equation (WHO) and the MedGem® a handheld indirect calorimeter device (MGREE) accurately predicts energy needs as compared
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to the gold standard indirect calorimeter (ICREE). Currently, there is a lack of evidence
evaluating the validity and reliability of the MGREE in the pediatric oncology
population. Additionally, due to a high prevalence of malnutrition in the pediatric
oncology patients, accurate prediction of energy requirements is vital for the reduction of
detrimental outcomes.
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CHAPTER 2
MATERIALS AND METHODS
Introduction
Patients were recruited from St. Jude Children’s Research Hospital. Their resting energy
expenditure (REE) will be obtained by three methods:
A.

Indirect calorimetry
1. MedGem®
2. Metabolic Cart

B.

Estimation Equations
1. World Health Organization Energy Equation (WHO)

Results obtained from MedGem® and standard equations are compared to indirect
calorimetry by metabolic cart. No additional energy factor for activity, stress, and growth
will be included into the final measurements.
Indirect Calorimetry by Metabolic Cart
The indirect calorimetry by ICREE system includes pneumotachograph, gas
analyzers, display monitor, computer, and printer. The system measures breath-by-breath
indices of oxygen consumption (VO2), carbon dioxide production (VCO2), respiratory
quotient, and resting energy expenditure. The patient’s information (gender, weight,
height, and age) and any current environmental factors are input into the system prior to
the measurement. Measurements are taken via a mouth piece with the Ultima
Cardiopulmonary Gas Exchange System (Medical Graphics Corporation, Minneapolis,
Minnesota). The Ultima system includes the following equipment: A Prevent
Pneumotach matched with a variable reluctance pressure transducer (calculates a factor
9

used to convert flow to volume), a zirconia fuel cell oxygen analyzer, and an infrared
carbon dioxide analyzer. All equipment is calibrated by rigorous, standardized
procedures prior to each use by a qualified pulmonary technician. During calibration the
pneumotachograph will send signals to the wave-form analyzer which verifies output and
volume for each breath. The gas analyzer is calibrated using room air and calibration gas
(12% oxygen, 5% carbon dioxide, and a nitrogen balance).
Indirect Calorimetry by MedGem®
Measurements using MGREE will be obtained via a mouthpiece provided by
HealtheTech, Inc. The handheld device measures VO2 and determines REE using a
constant respiratory quotient (RQ) of 0.85 with a maximum error of +/- 2.2%. An RQ of
0.85 is chosen as an RQ outside the range of 0.75 and 0.95 for an individual is extremely
rare even under pathophysiologic conditions.24 VCO2 is not included in the final measure.
When the device is turned on, it will immediately begin to self-calibrate to room
conditions of temperature, barometric pressure, and humidity, no operator input is
necessary.
Predictive Equation
The WHO predictive equations for ages 3-10 and 10-18 will be used to predict the
REE in the study population of 7-17 year olds. The equations take into account patient’s
weight in kilograms, age, and gender (Table 1).
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Table 1. World Health Organization Equation
World Health Organization Equation
*Weight (wt) measured in kilograms
Equation to Derive Resting Energy Expenditure in calories/day
Age Range (years)

Males

Females

3-10

(22.7 x wt) + 495

(22.5 x wt) + 499

10-18

(17.5 x wt) + 651

(12.2 X wt) + 746

Procedures

Measurements
Patients were randomly assigned to perform the ICREE or MGREE first. The two
tests were completed within 30 minutes of each other with the same procedure
parameters extending to both. Patients had to be fasting, except for water and
medications, after midnight the night before the study. Any parenteral or enteral nutrition
maintained a continuous infusion rate from midnight prior to the test.
Patients were escorted downstairs, by a study team member, to the pulmonary lab
at 6:30 am on the day of the test and rest for 30 minutes in a supine position in a quiet,
darkened, thermo-neutral room. One parent was permitted to stay in the room with the
child, but no one may enter/leave the room during the test except the pulmonary
technician. The patient had to lie in a supine position for the duration of both tests.
A trained pulmonary technician conducted the ICREE. The first five minutes of
the test were not included in the final results to allow the patient time to reach a steady
breathing rate. After completion of the test, the pulmonary technician accounted for any
outliers that affected the accuracy including patient movement, coughing, etc. and
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removed from the final total REE measurement. The modified Weir equation was used
to calculate energy equivalency from the VO2 and VCO2.
Trained members of the Clinical Nutrition Services (study team) performed the
MGREE test. MGREE exam takes approximately 10 minutes, in which the first two
minutes were not included to allow the patient to reach a steady breathing rate.
The calculation of the WHO equation took approximately 5 minutes, and required
patient’s current weight that was obtained from the patient’s medical chart. The equation
was calculated by a study team member on the same day as the MGREE and ICREE were
performed.
Participant Selection
Participants were selected by referral from clinicians and members of Clinical
Nutrition Services. All patients were reviewed and screened for eligible participants each
day by a member of the study team. After screening, a study team member will meet
with the eligible participant to discuss the quality improvement protocol (QI), and asked
if they were willing to participate.
Inclusion Criteria













Between the age of 7-18
Pediatric oncology patient admitted to St. Jude Children’s Research Hospital
Weight ≥ 15kg
Able to read/speak English
Not on supplemental oxygen
Not on ventilator support
No evidence of neuromuscular disorder
Has not received general anesthesia within 6-8 hours of measurement
Not on hemodialysis
Has not undergone any painful procedures within one hour of energy
measurement
Does not have a chest tube
Not requiring gastric decompression
12



Has not received analgesics or sedatives within 30 minutes prior to the
measurement

Ordering Process
The requests for REE in the Pulmonary Function Laboratory for a one hour time
block were placed in the PowerChart P134 system for all eligible participants that
voluntarily agreed to be a part of the QI protocol. The PowerChart P134 system is used
for all scheduling and ordering for all inpatients and outpatients throughout the facility.
Energy measurements obtained by the MGREE and the WHO equations were performed
at the same time as the metabolic cart, and did not require individual orders in the
computer system.
Staff Training
The Clinical Nutrition Services members who assisted on the QI protocol were
trained and checked off as competent by the nutrition project manager on how to use the
MGREE equipment and how to estimate REE using the standard WHO equation. The
Clinical Nutrition Services members included dietitians, dietetic graduate assistants, and
undergraduate assistants, thereafter known as a study team member. The metabolic cart
measurements were performed by a trained Pulmonary Technologist in the Pulmonary
Lab.
Data Collection
Data were recorded on data collection form, (Appendix A). Data forms are stored in a
locked office located in the Department of Clinical Nutrition. Electronic data sheets are
stored on a password protected computer in a locked office of the principal investigator.
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Data Reporting
All study forms were reviewed for completeness and accuracy by the QI project
manager. The nutrition project manager addressed any questions regarding the recorded
responses with the team member who interviewed the study participant and conducted the
REE measurements.
Statistical Consideration
Sample Size
The purpose of this QI project was to determine if the energy expenditure
obtained by standard energy estimation equations and a hand-held indirect calorimeter
MGREE accurately predicts energy needs as compared to the gold standard indirect
calorimeter by ICREE among pediatric oncology patients admitted for leukemia, solid
tumor, or neuro-oncology services. The hypothesis was that the two methods, the
MGREE and prediction equation, will differ from the ICREE in determining resting
energy expenditure requirements. As this is a QI project, there is no historical
information about how discordant they are. Therefore, a sample size was not suggested
for this QI. Instead, data was collected from pediatric oncology patients aged 7 to 17
years admitted to leukemia, solid tumor, neuro-oncology services over a 6-month period.
Statistical Analysis
A one way analysis of variance (ANOVA) was used to determine whether there
was a difference between the three methods. If a significant difference is detected then
pairwise comparisons will be made to determine which methods differ. A significance
level of 0.05 will be used and a Bonferonni adjustment will be made for the pairwise
comparisons to account for multiple testing.
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CHAPTER 3
RESULTS
Results
A randomized block design was used to compare the means of the three different
methods. The blocks for the analysis were the different subjects. The order that the
methods MedGem® and Cart were applied to the subjects (Table 2) was randomly
assigned. The analysis of variance (ANOVA) table for the randomized block design is
shown below (Table 3).

Table 2. Subject Characteristics
Characteristics
Male (%)
Female (%)
Median age (range)
Median weight (kg) (range)
Median height (cm) (range)
Diagnosis:
Solid Tumor (%)
Ewing’s Sarcoma
Osteosarcoma
Mixed Germ Tumor Cell
Desmoplastic small-round-cell
tumor
Brain Tumor (%)
Medulloblastoma
Glioma of brainstem
Glioblastoma
Basal Ganglia Germinoma
Ependymoma
Hematological
Acute lymphoblastic leukemia
Lymphoma, non-Hodgkins
Lymphoma, Hodgkins
Gastric tube (5)

Number (n=19)
12 (63)
7 (37)
13 (7-17)
49.1 (18.4-100.8)
160.4 (114.8-178.6)
6 (32)
1
3
1
1
6 (32)
2
1
1
1
1
7 (37)
5
1
1
1 (5)
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Table 3. Subjects’ Mean Responses
Degrees of
Sum of
Freedom
Squares
Subject
1
600633
Method
2
1422421
Residuals
53
5278246

Mean
Square
600633
711210
99590

F-value
6.0311
7.1414

p-value
0.0174
0.0018

The ANOVA table shows that with p-value = 0.0174, there is a significant
difference between the subjects’ mean responses. With p-value of 0.0018, there is also a
statistically significant difference between the Methods used. To evaluate which
Methods have different means, pairwise comparisons were computed with a Bonferroni
adjustment for multiple testing. The results are shown in the following table (Table 4).

Table 4. Difference Between Methods
Cart
Equation
0.340
MedGem
0.152

Equation
0.002

The entries in the table are the corresponding p-values for testing whether the pair
of Methods have different mean. For example the p-value for testing whether mean
response is the same using the Equation and the Cart is 0.340, indicating that there is no
statistically significant difference between mean response using the Cart and the
equation. From the table it is clear that the only two methods that differed significantly
in their mean response were the MedGem® and the equation with a p-value of 0.002.
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CHAPTER 4
DISCUSSION AND CONCLUSIONS
Brief Review
Accurate and reliable methods of measuring REE are essential when treating
pediatric oncology patients. The sensitive population is at an increased risk of
malnutrition related to varying metabolic states associated with a cancer diagnosis and
their treatment regimen.6 Estimating needs for this population is difficult, and requires
years of professional experience. Consequently, when the needs are estimated
inaccurately and not met, the patient can experience a range of complications from
decreased drug efficacy, post-treatment obesity and metabolic syndrome, and an
exponential increase in mortality risk.6,14 It is in imperative to find a safe reliable tool
that can estimate energy needs and prevent the previous mentioned complications.
Results Summary
The objective of this QI was to compare standard energy equations and a handheld indirect calorimeter, the MedGem®, to the gold-standard the metabolic cart in
pediatric oncology patients. The hypothesis was that the two methods, the MGREE and
prediction equation, will differ from the ICREE in determining resting energy
expenditure requirements. Per the results, the hypothesis was found to be partially
correct. Between the three methods of measurement there is a significant difference
when compared at the same time. However, when compared in a pairwise function, e.g.
MedGem®/cart or equation/cart, there were no significant differences. Meaning both the
MedGem® and estimation equation appear to be reliable tools to use when compared
solely with the cart. Oddly, when compared to one another, MedGem® versus equation,
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they are significantly different (p-value 0.002). After analyzing the data it appears that
the MedGem®has a tendency to underestimate energy needs while the equation tends to
overestimate which could be the cause of their significant differences. Again when
compared individually to the gold-standard they fall within range of reliability.
Study Comparison
In previous studies, the MedGem® has been found to be a valid tool for both
adults and children. A majority of these studies were focused on weight-loss, and the use
of the MedGem® in overweight or obese men and women.21,26 Both studies found that
the REE was measured higher when using the MedGem® compared to ICREE and the
equation. Even the study attempting to validate the MedGem® for use in adult oncology
patients found the MedGem® to overestimate REE when compared to ICREE and
predictive methods when analyzed using paired t-tests.21 The MedGem® does not take
into account VCO2, and therefore makes an assumption for the RQ leading to potential
errors. Anderson et. al, found a downward trend with the MedGem®. When participants
performed the measure again at a subsequent visit, the REE was lower. Anderson et. al
proposed the staff and participants had become more skilled at using the device, from
placing nose clips accurately to prevent air leakage and the participants were less anxious
and breathed more naturally.26 Fields et. al who validated the MedGem® for use in
healthy children found that the MedGem® results were significantly higher (p < 0.5) when
compared to metabolic cart when participants were sitting upright (1475 +/- 350 kcal/d)
versus in a supine position (1419 +/- 286 kcal/d).22
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Review of Methods
The measurements for the QI were performed at one point in time, and the use of
the MedGem® or metabolic cart was randomized for each participant. Therefore, it is not
known if the order of the measurements had an effect, or if subsequent visits with
additional practice by participants could have affected the REE. Participants were also
required to rest in a supine position for thirty minutes prior to testing. The resting
requirement may have had an effect on the MedGem® tendency to be slightly lower
(insignificant) than the metabolic cart. All of the measures were performed by the same
three study team members, and over half the measures being performed by one
individual. Staff training was an unlikely factor in accuracy of measures.
Limitations
The young age of the participants could affect the accuracy of the measures. It
was difficult for the children to sit still through the three measures (MGREE, ICREE, and
calculating predictive equations) totaling an average of 45 minutes. Only 19 participants
were used in the statistical analysis, possibly due to the short time frame of testing. Also,
a majority of patients were outpatients, and found it difficult to meet the 6:30am testing
time.
Conclusion
More participants are needed and further testing needs to be done to validate the
MedGem® as a useful tool before it can be safely implemented in a pediatric oncology
setting. The predictive equation used was measured closer to the metabolic cart then the
MedGem®. Predictive equations are less expensive and less time-consuming then both
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the MGREE and ICREE. As of now, the equation is the most practical tool to use in a
pediatric oncology outpatient and inpatient setting.
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APPENDIX A
DATA COLLECTION FORM

Clinical Nutrition Measuring REE
Today’s Date:_____________
Sex:  Male
____________
Weight:_____kg
score:_____

 Female

Age (7-18): ___________

Height:_____cm

BMI:_____ kg/m2

Race:

BMI:_____ %ile BMI z-

Nutrition Status (List nutrition diagnosis from most recent note and
date):__________________________
Fasting Status (NPO, except for water and medication since midnight):
 Fasting, proceed

 No, reschedule and educate

List Pertinent Medication (Include any pain meds, steroids, growth hormone, thyroid
medications, and nicotine: note when last dose was given ):
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
____________________________
Patient on Pain Medication:
 Yes, wait a minimum of 30 minutes after last dose to begin tests

 No, proceed

Continuous PN/EN Feeding Status (Cannot be adjusted within 12hrs of testing):
 Adjusted within 12 hours, do not proceed
 Tube Feeding

 TPN

Formula Name:____________

 Not adjusted, proceed

 No Nutrition Support

Rate of Formula:_____________

Review I/O sheet for provided nutrients for a 24hr period (7:00am – 6:59am the following day)
Providing: _______ kcals/kg _______pro/kg _______mls/m2
Resting Status (Supine position for ≥30 minutes)
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 Yes, proceed

 No, wait an additional 30 minutes

Mark REE Test Taking First (Second test MUST be performed within 10 minutes of first):
 MedGem®

 Metabolic Cart (Performed by Certified Pulmonary Technologist)
Metabolic Cart

Time test was taken: _________ Duration: ___________ REE(Attach copy of results):
___________
Issues during the test:
 No

 Yes, explain:______________________________________________________

Pulmonary Technician (Name and Signature):______________________
MedGem®
Time test was taken: __________ Duration: _____________ REE: _______________
Issues during the test:
 No

 Yes, explain:_______________________________________________________

Clinical Nutrition Staff Member (Name and Signature):_____________________
WHO Energy Equation
Use one of the following equations, based on subject information:
Please check the equation used
*Weight measured in kilograms
Age Range (years)

Males

Females

3-10

(22.7 x wt) + 495

(22.5 x wt) + 499

10-18

(17.5 x wt) + 651

(12.2 X wt) + 746

Time test was taken: __________ Duration: _____________ REE: _______________
Clinical Nutrition Staff Member (Name and Signature):_____________________

24

